Spero Therapeutics
SPRO
#10353
Rank
A$65.31 M
Marketcap
A$1.12
Share price
-10.20%
Change (1 day)
-69.62%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2026 (TTM): A$10.54 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are A$42.96 Million. In 2025 the company made an earning of A$10.81 Million, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$10.54 M-2.46%
2025 A$10.81 M-109.88%
2024 -A$0.11 Billion-360.42%
2023 A$42.05 M-163.53%
2022 -A$66.19 Million-50.14%
2021 -A$0.14 Billion11.06%
2020 -A$0.12 Billion25.15%
2019 -A$95.51 Million47.68%
2018 -A$64.68 Million5.61%
2017 -A$61.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
IBM
IBM
A$15.87 B 158,792.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
A$2.98 B 29,800.18%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
A$9.7 M-2.80%๐Ÿ‡บ๐Ÿ‡ธ USA